Identifying targeted therapies for CBFA2T3::GLIS2 acute myeloid leukemia
2026 · Leukemia · 0 citations
https://doi.org/10.1038/s41375-025-02845-7
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
4.1K
Citations
26
h-index
35
i10-index
Barbara Degar is an academic researcher from Dana-Farber Cancer Institute. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Autoimmune and Inflammatory Disorders Research & Parvovirus B19 Infection Studies. The author has an h-index of 26, co-authored 68 publications.
ORCID: 0000-0002-1295-6021https://doi.org/10.1038/s41375-025-02845-7
https://doi.org/10.1002/1545-5017.70030
Click to start Chat